Loading CPRX...
Catalyst Pharmaceuticals Inc.CPRXAs of 21 July 2026
+14
PositiveNegative
Equilibrium
Valuation
Is Catalyst Pharmaceuticals Inc. undervalued or overvalued?
Where Catalyst Pharmaceuticals Inc. (CPRX) trades across 21 valuation metrics, from price-to-sales and forward P/E to book and cash-flow multiples, each ranked against its own five-year history rather than a broad sector average, so you can see whether it is genuinely cheap or expensive on its own terms. Information, not advice.
Catalyst Pharmaceuticals Inc.CPRXLast 5 years
V—E—F—A—
——
CPRX priceasymmetryquant.com